1757. Misbranding: of Testavins.    V. S. v. 57 Bottles and 35 }& Dozen Bottles of
Testavins.    Default decrees of condemnation and destruction.    (F. D. C.
Nos. 16488, 16651.    Sample Nos. 455-H, 22966-H.)
LIBELS FILED : June 21 and 28, 1945, Eastern District of Missouri and Northern
District-of Georgia.
ALLEGED SHIPMENT :   On or about April 6 and May 10, 1945, by the Veltex Co.,
from Birmingham, Ala.
PRODUCT:   57 100-tabIet bottles of Testavins at St. Louis, Mo., and 23? dozen
20-tablet bottles and 11? dozen 100-tablet bottles of Testavins at Atlanta, Ga.
Examination showed that the article had essentially the composition claimed
on the label.
LABEL, IN PABT: "Testavins 100 [or "20"] Tablets Indicated in Functional
Impotence of Neurasthenic Origin * * * Each Tablet Contains: Vitamin
Bj . . . 666 U. S. P. Units Yohimbin Hydrochloride 0.0005 Gram
Orchic Substance 0.05 Gram Calcium Glycerophosphate 0.15 Gram Sodium
Glycerophosphate 0.15 Gram Extract Nux Vomica 0.03 Gram Distributed by
Vitamin Park   *    *   *   New York City."
NATURE OF CHARGE: Misbranding, Section 502 (a), all lots. The label state-
ments, "Indicated in Functional Impotence of Neurasthenic Origin * * *
Take 2 to 3 Tablets depending upon age and severity of Case," were false and
misleading since the article would not be effective for impotence.
Further misbranding, Atlanta lot. Section 502 (a), the label statement,
"Each Tablet Contains * * * Orchic Substance 0.05 Gram," was mislead-,
ing since it failed to reveal the material fact that orchic substance possesses
no therapeutic activity when taken by mouth; Section 502 (e), the label failed
to bear a statement of the quantity or proportion of the strychnine contained
in the article; and, Section 502 (f) (2), the label failed to warn that, in view
of the yohimbine hydrochloride present, the article should not be taken by
those suffering from heart disease, high blood pressure, or kidney disease, and
that an article containing nux vomica might be dangerous, especially when
used by elderly persons, and it also failed to warn that the use of a product
containing yohimbine hydrochloride should be discontinued if stomach dis-
turbance, nausea, vomiting, vertigo, or fainting occur.
DISPOSITION : July 27 and August 1, 1945. No claimant having appeared, judg-
ments of condemnation were entered and the product was ordered destroyed.